Group
Genomics
5 themes59 tickers
10D rank10D#8of 172 groups/172
Dive into Genomics, where we explore who's at the cutting edge of gene editing, sequencing hardware, and who interprets all that genetic data. These companies are all about unlocking life's code for biotech and creating healthcare breakthroughs.
Themes in this group
| Genomics '25: Sequencing Platforms & InstrumentsSequencing Platforms & Instruments | 7 | $85.58B | $599.03B | +1.90% | +17.73% | +29.61% | -1.52% | +58.60% | +78.40% | +87.53% | -17.92% | +48.62% | +51.67% | +54.49% | +117.89% | +5.30% | +0.74% |
| Genomics '25: Genomics Tools, Reagents & WorkflowsGenomics Tools, Reagents & Workflows | 12 | $23.54B | $282.51B | +2.75% | +5.43% | +16.69% | +2.52% | +80.26% | +95.10% | +51.86% | -1.79% | +26.38% | +47.74% | +65.93% | +113.33% | -5.46% | +22.35% |
| Genomics '25: Synthentic Biology & BiofoundriesSynthentic Biology & Biofoundries | 12 | $5.43B | $65.13B | +0.51% | +5.26% | +14.03% | +0.47% | +53.49% | +30.19% | +42.00% | -31.82% | +24.85% | +27.16% | +58.33% | +73.81% | +6.59% | +23.67% |
| Genomics '25: Clinical Genomics & Genomics TestingClinical Genomics & Genomics Testing | 18 | $7.36B | $132.51B | +2.24% | +1.28% | +16.25% | +1.70% | +49.27% | +73.57% | +201.24% | +146.12% | +41.75% | +57.58% | +70.39% | +155.59% | +11.89% | +33.19% |
| Genomics '25: Gene Editing & Genetic MedsGene Editing & Genetic Meds | 12 | $1.17B | $14.07B | -0.04% | -10.47% | -16.11% | +0.45% | +16.12% | -14.18% | +23.90% | -67.22% | -0.21% | -8.08% | +0.52% | +93.85% | +6.46% | -3.15% |
Default: 10D ↓ · Click headers to sort · Shift+click secondary